title: Reducing relapse in tuberculosis treatment: is it time to reassess WHO treatment guidelines?
authors.affiliation: Tuberculosis Services, British Columbia Centre for Disease Control, Vancouver, Canada.
authors.forename: James C
authors.initials: JC
authors.lastname: Johnston
authors.affiliation: Montreal Chest Institute, McGill University, Montréal, Canada.
authors.forename: Faiz Ahmad
authors.initials: FA
authors.lastname: Khan
authors.affiliation: Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
authors.forename: David W
authors.initials: DW
authors.lastname: Dowdy
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D017410:Practice Guidelines as Topic / Q000592:standards*; D012008:Recurrence; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D014944:World Health Organization
chemical_list: D000995:Antitubercular Agents